Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...

Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global ...

Success in cancer care increasingly includes survivorship outcomes, emphasizing durable function and symptom control for patients cured and those with prolonged metastatic disease. Variable survival ...

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their ...

Martei is a medical oncologist, cancer outcomes researcher, and an assistant professor of medicine at the University of Pennsylvania. As a medical oncologist, one of the first threats I inform new ...

The Department of Radiation Oncology is proud to announce the promotion of Michael Soike, M.D., to associate professor of Radiation Oncology. "Dr. Soike is an exceptional clinician, gifted educator, ...

A new study co-authored by University of Kentucky Markey Cancer Center researchers Jessica Burris, Ph.D., Timothy Mullett, M.D., and Graham Warren, M.D., Ph.D., shows that making smoking cessation ...

CHEYENNE – Cheyenne Regional Medical Center has announced a new partnership with University of Colorado Medicine (CU Medicine) to further strengthen the hospital’s high-quality radiation oncology ...

Foundation Medicine, Inc., a global precision medicine company, today announced the launch of its Whole Genome Sequencing (WGS) Germline test for research use. This important portfolio expansion is ...